Crystalline Glucosamine Sulfate in the Treatment of Osteoarthritis: Evidence of Long-Term Cardiovascular Safety from Clinical Trials

Table 2: Patients Shifting from Normal to Abnormal (Hypertensive) Blood Pressure Values, and Vice Versa, from Baseline to the End of Treatment (Month 6)

Patients on Placebo, n (%)
		Month 6		Total
		Normal	Abnormal	Total
Baseline	Normal	30 (39.0)	6 (7.8)	36 (46.8)
Baseline	Abnormal	17 (22.1)	24 (31.2)	41 (53.2)
Total		47 (61.0)	30 (39.0)	77 (100)
p=0.035
Patients on CGS, n (%)
		Month 6		Total
		Normal	Abnormal	Total
Baseline	Normal	41 (48.2)	6 (7.1)	47 (55.3)
Baseline	Abnormal	18 (21.2)	20 (23.5)	38 (44.7)
Total		59 (69.4)	26 (30.6)	85 (100)
p=0.023

This analysis takes into account patients for whom both values (baseline and 6-month) were available.Statistical analysis was done by McNemar test.CGS=crystalline glucosamine sulfate.